07:00 , Apr 26, 2004 |  BC Week In Review  |  Company News

Bioreason management update

Bioreason Inc. , Santa Fe, N.M.   Business: Bioinformatics   Hired: Andrew DePristo as president and CEO, formerly senior director of research and preclinical development information systems at Amgen Inc.  ...
08:00 , Feb 4, 2002 |  BC Week In Review  |  Company News

Bioreason sales and marketing update

Bioreason launched an automated compound selection module for its ClassPharmer high throughput screening analysis software. Bioreason Inc., Santa Fe, N.M.   Business: Bioinformatics, High throughput screening  ...
08:00 , Nov 5, 2001 |  BC Week In Review  |  Company News

Bioreason sales and marketing update

Bioreason launched its ClassPharmer high throughput screening analysis software tool. ClassPharmer uses topology-based technology for structural classification of chemical compounds. The company said the software can be used for high throughput screening analysis. Bioreason Inc.,...
07:00 , Sep 24, 2001 |  BC Week In Review  |  Company News

Bioreason, Pfizer deal

Bioreason licensed its DataPharmer, LeadPharmer and DrugPharmer software packages to PFE's Warner-Lambert division. The software analyzes data from high throughput screening for drug discovery. Bioreason Inc., Santa Fe, N.M.   Pfizer Inc. (PFE), New York,...
07:00 , Sep 21, 2001 |  BC Extra  |  Company News

Bioreason, Warner-Lambert license deal

Bioreason (Santa Fe, N.M.) licensed its DataPharmer, LeadPharmer and DrugPharmer software packages to Warner-Lambert , a division of Pfizer (PFE). The software analyzes data from high throughput screening for drug discovery....
07:00 , Sep 11, 2000 |  BC Week In Review  |  Company News

Biacore, Bioreason other research news

The partners presented data showing that the combination of BCOR's surface plasmon resonance (SPR)-based biosensor technology and Bioreason's predictive chemoinformatics software identified molecular groups that affect a compound's ability to bind to human serum albumin...
08:00 , Feb 22, 2000 |  BC Week In Review  |  Company News

Bioreason, Warner-Lambert deal

Bioreason and WLA’s Parke-Davis Pharmaceutical Research division (Ann Arbor, Mich.) extended a 1998 agreement to develop a second stage of Bioreason’s chemiinformatics systems for lead discovery. Bioreason Inc. , Santa Fe, N.M.   Warner-Lambert Co....
07:00 , Sep 20, 1999 |  BC Week In Review  |  Company News

Biacore AB, Bioreason deal

The companies will develop software and biosensor assay systems for drug absorption, distribution, metabolism and excretion (ADME) screening. BCOR will invest $900,000 in Bioreason equity to obtain a minority stake, and the companies will share...
07:00 , Sep 20, 1999 |  BC Week In Review  |  Company News

Bioreason board of directors update

(Deal, B3) Bioreason Inc., Santa Fe, N.M.   Business: Enabling technology   Appointed: Anders Wiklund, SVP of Biacore AB  ...
08:00 , Feb 1, 1999 |  BC Week In Review  |  Company News

Bioreason, Warner-Lambert deal

Warner-Lambert's Parke-Davis Pharmaceutical Research Division will use Bioreason's LeadFinder software system, which identifies activity mechanisms by providing 3-D modeling of compounds, with Parke-Davis' high throughput screening for data analysis. Parke-Davis will receive a non-exclusive license...